[250 Pages Report] The global demand for hospital supplies is expected to increase at 3.7% CAGR over the forecast period from 2022 to 2032. Sales in the hospital supplies market are estimated to reach a valuation of US$ 29.5 Billion in 2022. According to the study, hospitals held a substantial share of 47.2% in 2021 in the global hospital supplies market.
| Data Points | Market Insights |
|---|---|
| Hospital Supplies Market Value 2021 | US$ 28.6 Billion |
| Hospital Supplies Market Value 2022 | US$ 29.5 Billion |
| Hospital Supplies Market Value 2032 | US$ 42.3 Billion |
| Hospital Supplies Market CAGR 2022 to 2032 | 3.7% |
| Market Share of Top 5 Countries | 53.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the overall sales of hospital supplies grew at a CAGR of 3.3% between 2017 and 2021. However, the demand in the hospital supplies market is expected to increase at a CAGR of 3.5%, reaching US$ 42.3 Billion by the end of 2032.
The global hospital supplies market held around 20% of the global medical supplies market which was valued at nearly US$ 138 Billion in the year 2021.
Hospital settings and other healthcare units are at a greater risk of infections and viral exposure, resulting in a rising prevalence of hospital-acquired infections for over a decade. Several measures are being considered to prevent and reduce the prevalence rate such as the use of disposable procedure kits and trays, sterile and disposable products, sterile medical devices, disposable gloves, and other disposable medical supplies.
For instance, in March 2022, Becton, Dickinson & Company launched a TCR/BCR multi-omic assay which aids in speeding the discovery of infectious diseases, autoimmune disorders, and immune-oncology as well.
According to a survey conducted by CDC, in 2019, about 1 in 31 patients had at least one healthcare-associated infection. In addition, it is also noticed that the prevalence rate of hospital-acquired infections in low-income countries is far higher than in high-income countries.
For instance, a study published in the International Journal of Research and Public Health in 2020 states that a 7.5% prevalence of hospital-acquired infection was observed in high-income countries, although others have reported rates of 4.5% in the USA and 5.7%-7.1% in Europe, while in low- and middle-income countries, however, the prevalence rate ranged between 5.7% and 19.2%.
The hospital supplies market includes different product types such as wound care products, dialysis products, sterilization consumables, infusion products, and hypodermic and radiology products amongst others.
Based on product, hypodermic and radiology products like syringes, needles and consumable products for radiography and ultrasound were the dominant market segment in the global market in 2021, which contributed 17.6% of the revenue share.
The global hospital supplies market is expected to be valued at US$ 42.3 Billion by the end of 2032, registering a CAGR of 3.7% over the forecast period.
Growing awareness regarding health & hygiene practices, particularly in hospitals will offer lucrative opportunities to market players. The rising disposable income and large patient pool due to a lack of awareness regarding hygiene in emerging economies will drive sales in the market.
Increasing expenditure on healthcare services is leading to the emergence of more and new hospitals worldwide, which in turn, is spurring demand for hospital supplies.
Other factors such as the growth in nosocomial infections have not only increased the mortality and morbidity rate but also the healthcare burden by stretching the length of hospitalization. Therefore, organizations such as the CDC and WHO are putting immense efforts into layout guidelines and conducting vigorous studies to control the occurrence of hospital-acquired infections.
However, despite these efforts, there is still a significant rise in the prevalence of these infections. Thus, increasing research and development efforts to develop hygienic solutions in the hospital supplies industry to minimize exposure to infection and other viral diseases expect to uncap lucrative opportunities in the hospital supplies market.
Principal Consultant
Lack of awareness regarding hospital-acquired infection and hygiene in developing countries is contributing to the rapid rise of hospital-acquired infection in these countries. According to a study published in the Journal of Epidemiology and Community Health, more than 20% of all hospital-acquired infections are associated with intensive care unit visits.
Most emerging nations have about 2-3-fold higher hospital-acquired infection populations. Thus, the lack of awareness in developing countries regarding hospital-acquired infection and its diagnosis is projected to restrict the growth in the hospital-acquired infection testing market. This is expected to have a negative impact on sales of hospital supplies.
When most countries in the developed regions have strongly built health insurance coverage, these policies are less spread in developing countries. World Health Organization states that the world's partial population is not able to obtain essential health services.
According to a national survey, only one-fifth of the Indian population is insured under health insurance.
Most health insurance schemes do not cover disposables such as disposable gloves or masks utilized during surgical procedures. This adds to the overall cost imparted on the patient’s budget. Thus, the lack of proper health insurance that covers essential healthcare services and the cost of various hospital supplies in underdeveloped and developing countries may restrain the growth in the hospital supplies market.
Rising Demand for Wound Care Products in the USA to Fuel Growth
According to FMI, the USA is expected to dominate the North American hospital supplies market, with a total market share of 92.8% in 2021, and is projected to continue to exhibit high growth through 2022 & beyond.
According to CDC, approximately 5% of patients acquire hospital-associated infections in developed countries. Hence, rising in the number of patient admissions, high demand for treatment, and increased prevalence of hospital-acquired infection and adoption of medical hygiene practices will continue pushing sales in the USA.
Growth in the Medical Automation Market in Germany will Spur Demand for Hospital Supplies
Germany is set to exhibit growth at a CAGR of around 3.5% in the Europe hospital supplies market during the forecast period. Rising awareness of hospital-acquired infection and strong healthcare infrastructure, attractive reimbursement policies along with the best Research and Development performance in the industry will drive the growth of the hospital supplies market in Germany.
Expansion of the Portable Medical Devices Market in China Will Fuel Growth
Sales in the China market are projected to expand at a CAGR rate of 4.1% and hold about half of the East Asia hospital supplies market share and are expected to dominate throughout the forecast period, finds FMI.
Growing investments in research & development activities and technological advancements in the healthcare sector will drive sales in the market. China is expected to spearhead the growth in East Asia due to technological advancement, wide availability of consumable medical supply products, and the presence of numerous players in the healthcare sector.
Rising Demand for Sterile and Disposable Products Will Boost the India Market
Total demand in India accounted for 45.3% of the market share in 2021 and is projected to increase with a CAGR of 4.0% over the forecast period. Growing prevalence of antibacterial-resistant infections and hospital-acquired infections spurring demand for hospital supplies.
With rising expenditure on healthcare services, developing economies like India are focussing more on innovation and technology in the healthcare sector which is in turn fuelling the hospital supplies market within the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Sales of Hypodermic and Radiology Products to Remain High
Based on product type, the hypodermic and radiology products segment accounted for 17.6% of the global market share in 2021. Sales in this segment are forecast to increase at a CAGR of 3.6% over the forecast period. Products like needles and syringes are routinely used in hospitals or diagnostic labs for drawing blood or injecting medicines.
On the other hand, radiology equipment like X-ray machines and C-Arms which are often employed in routine diagnosis by doctors, especially during surgical procedures require related disposable products to avoid spreading the infection to patients.
Demand for Hospital Supplies in the Hospital Segment Will Gain Momentum
By end-user, the hospital segment held a market share of 47.2% in 2021, with sales poised to grow at a CAGR of 3.9% over the upcoming decade. Hospitals have a large patient population and are exposed to numerous viral infections. Thus, to minimize the prevalence of healthcare-associated infection, hospitals are focusing on maintaining a hygienic environment which in turn is spurring demand for hospital supplies.
The hospital supplies market is highly fragmented. There are numerous players in the global market involved in developing cutting-edge solutions for the development of efficient products that can meet their customer’s needs.
Leading hospital supplies manufacturers are focusing on mergers, acquisitions, collaborations, and new product launches to increase sales and expand their global footprint. They are also focusing on improving their market presence by expanding their product line across countries to capitalize on untapped opportunities. For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the UK, Germany, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Turkey, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled | GE Healthcare; Medtronic (Covidien); Thermo Fischer Scientific Inc.; Becton, Dickinson, and Company; Cardinal Heath; Boston Scientific Corporation; B. Braun Melsungen AG; 3M Science; Molnlycke Health Care AB; Advanced Sterilization Services; Terumo; Baxter; Kimberly-Clark Corporation; Steris Corporation; Stryker Corporation; Getinge AB; Johnson and Johnson |
The global hospital supplies market is expected to be worth US$ 29.5 Billion in 2022 and is set to expand by 1.4X over the next ten years.
The hospital supplies market is expected to reach US$ 42.3 Billion by end of 2032, exhibiting growth at a CAGR of 3.7% between 2022 and 2032.
Key trends influencing sales in the hospital supplies market include increasing adoption of advanced hospital supplies, higher consumption of hospital supplies and strategic collaborations, mergers, and acquisitions among key players.
South Asia is expected to lead the global market, contributing over 23% of the revenue share in 2021.
The U.S., Japan, China, Germany, and India are the top five countries, which are expected to drive demand in the hospital supplies market.
GE Healthcare, Medtronic (Covidien), Thermo Fischer Scientific Inc., Becton, Dickinson and Company, Cardinal Heath, Boston Scientific Corporation, B. Braun Melsungen AG, 3M Science, Molnlycke Health Care AB, Advanced Sterilization Services, Terumo, Baxter, Kimberly-Clark Corporation, Steris Corporation, Stryker Corporation, Getinge AB, Johnson and Johnson are the key manufacturers in this market.
1. Executive Summary | Hospital Supplies Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global Healthcare Expenditure Outlook 4.1.2. Growth of the Healthcare Sector in Emerging Nations 4.1.3. Global Market 4.2. Forecast Factors - Relevance & Impact 4.2.1. Usage of Disposable Supplies 4.2.2. Increase in Demand for Disposable Supplies 4.2.3. Impact of Covid 4.2.4. Strategic Collaborations 4.2.5. Frequency of Product Launches 4.2.6. Rise of healthcare spending in developing economies 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. COVID-19 Crisis Analysis 5.1. COVID-19 and Impact Analysis 5.1.1. Revenue By Product Type 5.1.2. Revenue By End User 5.1.3. Revenue By Region 5.2. 2021 Market Scenario 6. Key Success Factors 6.1. Product Adoption/ Usage Analysis 6.2. Product USPs/ features 6.3. Key Promotional Strategies, By Key Manufacturers 6.4. Regulatory Scenario 6.5. Reimbursement Scenario 6.6. Value Chain Analysis 7. Global Market Demand (in Value or Size in US$ Billion) Analysis 2017 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Billion) Analysis, 2017 to 2021 7.2. Current and Future Market Size (US$ Billion) and Forecast Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Billion) By Product Type, 2017 to 2021 8.3. Current and Future Market Size (US$ Billion) and Forecast By Product Type, 2022 to 2032 8.3.1. Sterilization Consumables 8.3.2. Wound Care Product 8.3.3. Dialysis Product 8.3.4. Infusion Product 8.3.5. Hypodermic & Radiology Product 8.3.6. Intubation & Respiratory Supplies 8.3.7. Surgical Procedure Kits & Trays 8.3.8. Blood Management & Diagnostic Supplies 8.3.9. General Disposable Product 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Billion) By End User, 2017 to 2021 9.3. Current and Future Market Size (US$ Billion) and Forecast By End User, 2022 to 2032 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Clinics 9.3.4. Diagnostic Centers 9.3.5. Long-Term Care Centers 9.3.6. Nursing Facilities 9.4. Market Attractiveness Analysis By End User 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Billion) and By Region, 2017 to 2021 10.3. Current and Future Market Size (US$ Billion) and Forecast By Region, 2022 to 2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 11.1. Introduction 11.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021 11.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 11.3.1. By Country 11.3.1.1. United States of America 11.3.1.2. Canada 11.3.2. By Product Type 11.3.3. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product Type 11.4.3. By End User 11.5. Market Trends 11.6. Key Market Participants - Intensity Mapping 11.7. Drivers and Restraints - Impact Analysis 11.8. Country-Level Analysis & Forecast 11.8.1. USA Market Analysis 11.8.1.1. Introduction 11.8.1.2. Market Analysis and Forecast by Market Taxonomy 11.8.1.2.1. By Product Type 11.8.1.2.2. By End User 11.8.2. Canada Market Analysis 11.8.2.1. Introduction 11.8.2.2. Market Analysis and Forecast by Market Taxonomy 11.8.2.2.1. By Product Type 11.8.2.2.2. By End User 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021 12.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Product Type 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product Type 12.4.3. By End User 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 12.8. Country-Level Analysis & Forecast 12.8.1. Brazil Market Analysis 12.8.1.1. Introduction 12.8.1.2. Market Analysis and Forecast by Market Taxonomy 12.8.1.2.1. By Product Type 12.8.1.2.2. By End User 12.8.2. Mexico Market Analysis 12.8.2.1. Introduction 12.8.2.2. Market Analysis and Forecast by Market Taxonomy 12.8.2.2.1. By Product Type 12.8.2.2.2. By End User 12.8.3. Argentina Market Analysis 12.8.3.1. Introduction 12.8.3.2. Market Analysis and Forecast by Market Taxonomy 12.8.3.2.1. By Product Type 12.8.3.2.2. By End User 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021 13.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 13.3.1. By Country 13.3.1.1. United Kingdom 13.3.1.2. Germany 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Product Type 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product Type 13.4.3. By End User 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country-Level Analysis & Forecast 13.8.1. UK Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product Type 13.8.1.2.2. By End User 13.8.2. Germany Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product Type 13.8.2.2.2. By End User 13.8.3. France Market Analysis 13.8.3.1. Introduction 13.8.3.2. Market Analysis and Forecast by Market Taxonomy 13.8.3.2.1. By Product Type 13.8.3.2.2. By End User 13.8.4. Italy Market Analysis 13.8.4.1. Introduction 13.8.4.2. Market Analysis and Forecast by Market Taxonomy 13.8.4.2.1. By Product Type 13.8.4.2.2. By End User 13.8.5. Spain Market Analysis 13.8.5.1. Introduction 13.8.5.2. Market Analysis and Forecast by Market Taxonomy 13.8.5.2.1. By Product Type 13.8.5.2.2. By End User 13.8.6. BENELUX Market Analysis 13.8.6.1. Introduction 13.8.6.2. Market Analysis and Forecast by Market Taxonomy 13.8.6.2.1. By Product Type 13.8.6.2.2. By End User 13.8.7. Russia Market Analysis 13.8.7.1. Introduction 13.8.7.2. Market Analysis and Forecast by Market Taxonomy 13.8.7.2.1. By Product Type 13.8.7.2.2. By End User 14. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Billion) and Trend Analysis & Forecast By Market Taxonomy, 2017 to 2021 14.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Product Type 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product Type 14.4.3. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country-Level Analysis & Forecast 14.8.1. India Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product Type 14.8.1.2.2. By End User 14.8.2. Indonesia Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product Type 14.8.2.2.2. By End User 14.8.3. Malaysia Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product Type 14.8.3.2.2. By End User 14.8.4. Thailand Market Analysis 14.8.4.1. Introduction 14.8.4.2. Market Analysis and Forecast by Market Taxonomy 14.8.4.2.1. By Product Type 14.8.4.2.2. By End User 15. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021 15.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product Type 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product Type 15.4.3. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country-Level Analysis & Forecast 15.8.1. China Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product Type 15.8.1.2.2. By End User 15.8.2. Japan Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product Type 15.8.2.2.2. By End User 15.8.3. South Korea Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product Type 15.8.3.2.2. By End User 16. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017 to 2021 16.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product Type 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Product Type 16.4.2. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country-Level Analysis & Forecast 16.8.1. Australia Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product Type 16.8.1.2.2. By End User 16.8.2. New Zealand Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product Type 16.8.2.2.2. By End User 17. Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Billion) and Trend Analysis & Forecast By Market Taxonomy, 2017 to 2021 17.3. Current and Future Market Size (US$ Billion) and Forecast By Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. Turkey 17.3.1.2. GCC Countries 17.3.1.3. North Africa 17.3.1.4. South Africa 17.3.1.5. Rest of MEA 17.3.2. By Product Type 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product Type 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country-Level Analysis & Forecast 17.8.1. Turkey Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product Type 17.8.1.2.2. By End User 17.8.2. GCC Countries Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product Type 17.8.2.2.2. By End User 17.8.3. North Africa Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product Type 17.8.3.2.2. By End User 17.8.4. South Africa Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product Type 17.8.4.2.2. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional Footprint of Players 18.4.2. Product Footprint by Players 18.4.3. Channel Footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1.1. GE Healthcare 19.3.1.1.1. Overview 19.3.1.1.2. Component Portfolio 19.3.1.1.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.1.4. Sales Footprint 19.3.1.1.5. Strategy Overview 19.3.1.1.5.1. Marketing Strategies 19.3.1.1.5.2. Channel Strategies 19.3.1.1.5.3. Product Strategies 19.3.1.2. Medtronic (Covidien) 19.3.1.2.1. Overview 19.3.1.2.2. Component Portfolio 19.3.1.2.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.2.4. Sales Footprint 19.3.1.2.5. Strategy Overview 19.3.1.2.5.1. Marketing Strategies 19.3.1.2.5.2. Channel Strategies 19.3.1.2.5.3. Product Strategies 19.3.1.3. Thermo Fischer Scientific Inc. 19.3.1.3.1. Overview 19.3.1.3.2. Component Portfolio 19.3.1.3.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.3.4. Sales Footprint 19.3.1.3.5. Strategy Overview 19.3.1.3.5.1. Marketing Strategies 19.3.1.3.5.2. Channel Strategies 19.3.1.3.5.3. Product Strategies 19.3.1.4. Becton, Dickinson, and Company 19.3.1.4.1. Overview 19.3.1.4.2. Component Portfolio 19.3.1.4.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.4.4. Sales Footprint 19.3.1.4.5. Strategy Overview 19.3.1.4.5.1. Marketing Strategies 19.3.1.4.5.2. Channel Strategies 19.3.1.4.5.3. Product Strategies 19.3.1.5. Cardinal Heath 19.3.1.5.1. Overview 19.3.1.5.2. Component Portfolio 19.3.1.5.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.5.4. Sales Footprint 19.3.1.5.5. Strategy Overview 19.3.1.5.5.1. Marketing Strategies 19.3.1.5.5.2. Channel Strategies 19.3.1.5.5.3. Product Strategies 19.3.1.6. Boston Scientific Corporation 19.3.1.6.1. Overview 19.3.1.6.2. Component Portfolio 19.3.1.6.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.6.4. Sales Footprint 19.3.1.6.5. Strategy Overview 19.3.1.6.5.1. Marketing Strategies 19.3.1.6.5.2. Channel Strategies 19.3.1.6.5.3. Product Strategies 19.3.1.7. B. Braun Melsungen AG 19.3.1.7.1. Overview 19.3.1.7.2. Component Portfolio 19.3.1.7.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.7.4. Sales Footprint 19.3.1.7.5. Strategy Overview 19.3.1.7.5.1. Marketing Strategies 19.3.1.7.5.2. Channel Strategies 19.3.1.7.5.3. Product Strategies 19.3.1.8. 3M Science 19.3.1.8.1. Overview 19.3.1.8.2. Component Portfolio 19.3.1.8.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.8.4. Sales Footprint 19.3.1.8.5. Strategy Overview 19.3.1.8.5.1. Marketing Strategies 19.3.1.8.5.2. Channel Strategies 19.3.1.8.5.3. Product Strategies 19.3.1.9. Molnlycke Health Care AB 19.3.1.9.1. Overview 19.3.1.9.2. Component Portfolio 19.3.1.9.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.9.4. Sales Footprint 19.3.1.9.5. Strategy Overview 19.3.1.9.5.1. Marketing Strategies 19.3.1.9.5.2. Channel Strategies 19.3.1.9.5.3. Product Strategies 19.3.1.10. Advanced Sterilization Services 19.3.1.10.1. Overview 19.3.1.10.2. Component Portfolio 19.3.1.10.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.10.4. Sales Footprint 19.3.1.10.5. Strategy Overview 19.3.1.10.5.1. Marketing Strategies 19.3.1.10.5.2. Channel Strategies 19.3.1.10.5.3. Product Strategies 19.3.1.11. Terumo 19.3.1.11.1. Overview 19.3.1.11.2. Component Portfolio 19.3.1.11.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.11.4. Sales Footprint 19.3.1.11.5. Strategy Overview 19.3.1.11.5.1. Marketing Strategies 19.3.1.11.5.2. Channel Strategies 19.3.1.11.5.3. Product Strategies 19.3.1.12. Baxter 19.3.1.12.1. Overview 19.3.1.12.2. Component Portfolio 19.3.1.12.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.12.4. Sales Footprint 19.3.1.12.5. Strategy Overview 19.3.1.12.5.1. Marketing Strategies 19.3.1.12.5.2. Channel Strategies 19.3.1.12.5.3. Product Strategies 19.3.1.13. Kimberly-Clark Corporation 19.3.1.13.1. Overview 19.3.1.13.2. Component Portfolio 19.3.1.13.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.13.4. Sales Footprint 19.3.1.13.5. Strategy Overview 19.3.1.13.5.1. Marketing Strategies 19.3.1.13.5.2. Channel Strategies 19.3.1.13.5.3. Product Strategies 19.3.1.14. Steris Corporation 19.3.1.14.1. Overview 19.3.1.14.2. Component Portfolio 19.3.1.14.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.14.4. Sales Footprint 19.3.1.14.5. Strategy Overview 19.3.1.14.5.1. Marketing Strategies 19.3.1.14.5.2. Channel Strategies 19.3.1.14.5.3. Product Strategies 19.3.1.15. Stryker Corporation 19.3.1.15.1. Overview 19.3.1.15.2. Component Portfolio 19.3.1.15.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.15.4. Sales Footprint 19.3.1.15.5. Strategy Overview 19.3.1.15.5.1. Marketing Strategies 19.3.1.15.5.2. Channel Strategies 19.3.1.15.5.3. Product Strategies 19.3.1.16. Getinge AB 19.3.1.16.1. Overview 19.3.1.16.2. Component Portfolio 19.3.1.16.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.16.4. Sales Footprint 19.3.1.16.5. Strategy Overview 19.3.1.16.5.1. Marketing Strategies 19.3.1.16.5.2. Channel Strategies 19.3.1.16.5.3. Product Strategies 19.3.1.17. Johnson and Johnson 19.3.1.17.1. Overview 19.3.1.17.2. Component Portfolio 19.3.1.17.3. Profitability by Market Segments (Component/Channel/Region) 19.3.1.17.4. Sales Footprint 19.3.1.17.5. Strategy Overview 19.3.1.17.5.1. Marketing Strategies 19.3.1.17.5.2. Channel Strategies 19.3.1.17.5.3. Product Strategies 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Hospital Supplies Market
